Mr. Matthew Davis reports

THREED CAPITAL INC. ANNOUNCES PRIVATE PLACEMENT WITH SARIEL DIAGNOSTICS CORP.

ThreeD Capital Inc. has arranged a private placement with Sariel Diagnostics Corp., a privately held corporation existing under the laws of the Province of British Columbia. Per the terms of the private placement, ThreeD will acquire 3.75 million common shares of Sariel at a price of two cents per share. In consideration, ThreeD will issue an aggregate of 150,000 common shares of the company at a deemed price of 50 cents per common share. The private placement remains subject to the approval of the Canadian Securities Exchange.

About ThreeD Capital Inc.

ThreeD is a publicly traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD's investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the company's ecosystem.

We seek Safe Harbor.